[1]
|
Thubrikar, M.J., Nolan, S.P., Aouad, J. and Deck, J.D. (1986) Stress Sharing between the Sinus and Leaflets of Canine Aortic Valve. Annals of Thoracic Surgery, 42, 434-440.
|
[2]
|
Parashara, D.K., Jacobs, L.E., Kotler, M.N., Yazdanfar, S., Spielman, S.R., Janzer, S.F. and Bemis, C.E. (1995) Angina Caused by Systolic Compression of the Left Coronary Artery as a Result of Pseudoaneurysm of the Mitral-Aortic Intervalvular Fibrosa. American Heart Journal, 129, 417-421.
|
[3]
|
Aikawa, E., Nahrendorf, M., Figueiredo, J.L., Swiirski, F.K., Shtatland, T., Kohler, R.H., Jaffer, F.A., Aikawa, M. and Weissleder, R. (2007) Osteogenesis Associates with In-flammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging in Vivo. Circulation, 116, 2841-2850. https://doi.org/10.1161/CIRCULATIONAHA.107.732867
|
[4]
|
Vaslef, S.N. and Roberts, W.C. (1993) Early Descriptions of Aortic Valve Stenosis. American Heart Journal, 125, 1465-1474.
|
[5]
|
Coombs, O.F. (1924) Rheumatic Heart Disease. William Wood And Co., New York.
|
[6]
|
Christian, H.A. (1931) Aortic Stenosis with Calcification of the Cusps: Distinct Clinical Entity. The Journal of the American Medical Association, 97, 158.
|
[7]
|
Clawson, B.J., Noble, J.F. and Lufkin, N.H. (1938) The Calcified Nodular Deformity of the Aortic Valve. American Heart Journal, 15, 58.
|
[8]
|
Dry, T.J. and Willius, F.A. (1939) Calcareous Disease of The Aortic Valve. American Heart Journal, 17,138.
|
[9]
|
Hamburger, W.W. and Saphir, O. (1939) Aortic Stenosis. Modern Concepts of Cardiovascular Disease, 8, No. 2.
|
[10]
|
Edwards, J.E. (1961) An Atlas of Acquired Diseases of the Heart and Great Vessels. W.B. (Walter Burns) Saunders, Co., Philadelphia.
|
[11]
|
Messika-Zeitoun, D., Bielak, L.F., Peyser, P.A., et al. (2007) Aortic Valve Calcifica-tion: Determinants and Progression in the Population. Arteriosclerosis, Thrombosis and Vascular Biology, 27, 642-648. https://doi.org/10.1161/01.ATV.0000255952.47980.c2
|
[12]
|
Mohler, E.R., Gannon, F., Reynolds, C., Zimmerman, R., Keane, M.G. and Kaplan, F.S. (2001) Bone Formation and Inflammation in Cardiac Valves. Circulation, 103, 1522-1528. https://doi.org/10.1161/01.CIR.103.11.1522
|
[13]
|
Parhami, F., Morrow, A.D., Balucan, J., et al. (1997) Lipid Oxidation Prod-ucts Have Opposite Effects on Calcifying Vascular Cell and Bone Cell Differentiation: A Possible Explanation for the Paradox of Arterial Calcification in Osteoporotic Patients. Arteriosclerosis Thrombosis and Vascular Biology, 17, 680-687. https://doi.org/10.1161/01.ATV.17.4.680
|
[14]
|
Wylie-Sears, J., Aikawa, E., Levine, R.A., Yang, J.H. and Bischoff, J. (2011) Mitral Valve Endothelial Cells with Osteogenic Differentiation Potential. Arteriosclerosis, Thrombosis and Vascular Biology, 31, 598-607. https://doi.org/10.1161/ATVBAHA.110.216184
|
[15]
|
Kaden, J.J., Dempfle, C.E., Grobholz, R., et al. (2003) Inter-leukin-1 Beta Promotes Matrix Metalloproteinase Expression and Cell Proliferation in Calcific Aortic Valve Stenosis. Atherosclerosis, 170, 205-211.
|
[16]
|
Kaden, J.J., Dempfle, C.E., Grobholz, R., et al. (2005) Inflammatory Regulation of Extracellular Matrix Re-modeling in Calcific Aortic Valve Stenosis. Cardiovascular Pathology, 14, 80-87
|
[17]
|
Winchester, R., Wiesendanger, M., O’Brien, W., Zhang, H.Z., Maurer, M.S., Gillam, L.D., Schwartz, A., Marboe, C. and Stewart, A.S. (2011) Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves Calcific Aortic Stenosis. Journal of Immunology, 187, 1006-1014. https://doi.org/10.4049/jimmunol.1003521
|
[18]
|
Rajamannan, N.M. Subramaniam, M., Caira, F., Stock, S.R. and Spelsberg, T.C. (2005) Atorvastatin Inhibits Hypercholesteremia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway. Circulation, 112, 1229-1234.
|
[19]
|
Rajamannan, N.M., Subramanium, M., Rickard, D., et al. (2003) Human Aortic Valve Calcification Is Associated with an Osteoblast Phenotype. Circulation, 107, 2181-2184. https://doi.org/10.1161/01.CIR.0000070591.21548.69
|
[20]
|
Garg, V., Muth, A.N., Ransom, J.F., et al. (2005) Mutations in NOTCH 1 Cause Aortic Valve Disease. Nature, 437, 270-274. https://doi.org/10.1038/nature03940
|
[21]
|
Sacks, M.S. and Schoen, F.J. (2002) Collagen Fiber Disruption Occurs Independent of Calcification in Clinically Explanted Bioprosthetic Heart Valves. Journal of Biomedical Material Research, 62,359-371. https://doi.org/10.1002/jbm.10293
|
[22]
|
Matsumoto, Y., Adam, V., Walther, C., Kleinecke, C., Brugger, P., Linke, A., Walther, T., Mohr, F.W. and Schaller, G. (2009) Reduced Number and Function of Endothelial Progenitor Cells in Patients with Aortic Valve Stenosis: A Novel Concept for Valvular Endothelial Cell Repair. European Heart Journal, 30, 346-355. https://doi.org/10.1093/eurheartj/ehn501
|
[23]
|
Kovacic, J.C., Mercader, N., Torres, M., Boehm, M. and Fuster, V. (2012) Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition from Cardiovascular Development to Disease. Circulation, 125, 1795-1808. https://doi.org/10.1161/CIRCULATIONAHA.111.040352
|
[24]
|
Piera-Velazquez, S., Li, Z. and Jimenez, S.A. (2011) Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic Disorders. American Journal of Pathology, 179, 1074-1080.
|
[25]
|
Bostrom, K.I., Rajamannan, N.H. and Towler, D.A. (2001) The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens. Circulation Research, 109, 564-577. https://doi.org/10.1161/CIRCRESAHA.110.234278
|
[26]
|
Johnson, R.C., Leopold, J.A. and Loscalzo, J. (2006) Vascular Cal-cification: Pathobiological Mechanisms and Clinical Implications. Circulation Research, 99, 1044-1059. https://doi.org/10.1161/01.RES.0000249379.55535.21
|
[27]
|
Liu, A.C., Joag, V.R. and Gotlieb, A.I. (2007) The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology. American Journal of Pathology, 171, 1407-1418. https://doi.org/10.2353/ajpath.2007.070251
|
[28]
|
Caira, F.C., Stock, S.R., Gleason, T.G., et al. (2006) Human Degenerative Valve Disease Is Associated with Up-Regulation of Low-Density Lipoprotein Receptor-Related Protein 5 Receptor-Mediated Bone Formation. Journal of American College of Cardiology, 47, 1707-1712.
|
[29]
|
Kaden, J.J., Bickelhaupt, S., Grobholz, R., et al. (2004) Receptor Activator of Nuclear Factor Kappa B Ligand and Osteoprotegerin Regulate Aortic Valve Calcification. Journal of Molecular And Cellular Cardiology, 36, 57-66.
|
[30]
|
Chen, J.H., Yip, C.Y., Sone, E.D. and Simmons, C.A. (2009) Identification and Char-acterization of Aortic Valve Mesenchymal Progenitor Cells with Robust Osteogenic Calcification Potential. American Journal of Pathology, 174, 1109-1119. https://doi.org/10.2353/ajpath.2009.080750
|
[31]
|
Schoppet, M., Kavurma, M.M., Hofbauer, J.L.C. and Shanahan, C.M. (2011) Crystallizing Nanoparticles Derived from Vascular Smooth Muscle Cells Contain the Calcification Inhibitor Osteoprotegerin. Biochemical and Biophysical Research Communications, 407, 103-107.
|
[32]
|
Wuthis, R.E. and Lipscomb, G.F. (2011) Matrix Vesicles: Structure, Composition, Formation and Function in Calcification. Frontiers in Bioscience, 17, 2812-2902.
|
[33]
|
Miller, V.M., Rodgers, G., Charlesworth, J.A., Kirkland, B., Severson, S.R., Rasmussen, T.E., Yagubyan, M., Rodgers, J.C., Cockerill, F.R. III, Folk, R.T., Rzewuska-Lech, E., Kumar, V., Farell-Bard, G. and Lieska, J.C. (2004) Evidence of Nanobacterial-Like Structures in Calcified Human Arteries and Cardiac Valves. American Journal of Physiology: Heart and Circu-latory Physiology, 287, H1115-H1124.
|
[34]
|
Domingo, A., Carrascal, Y., Mota, P., Martin-Luengo, C., Bermejo, J., San Roman, J.A., Rodriguez-Torres, A. and Fernandez-Aviles, F. (2008) Association between Self-Replicating Calcifying Nanoparticles and Aortic Stenosis. A Possible Link to Valve Calcification. European Heart Journal, 29, 371-376. https://doi.org/10.1093/eurheartj/ehm592
|
[35]
|
Schlieper, G., Kruger, T., Heiss, A. and Jahnen-Dechent, W. (2011) A Red Herring in Vascular Calcification: “Nanobacteria” Are Protein-Mineral Complexes Involved in Biomineralization. Nephrology Dialysis Transplantation, 26, 3436-3439. https://doi.org/10.1093/ndt/gfr521
|
[36]
|
Chen, J.H. and Simmons, C.A. (2011) Cell-Matrix Interaction S in the Pathobiology of Calcific Aortic Valve Disease: Critical Roles for Matricellular, Matricrine, and Matrix Mechanic Cues. Circulation Research, 108, 1510-1524. https://doi.org/10.1161/CIRCRESAHA.110.234237
|
[37]
|
Mazzone, A., Epistolato, M.C., De Caterina, R., et al. (2004) Neoangiogenesis, T-Lymphocyte Infiltration and Heat Shock Protein-60 Are Biological Hallmarks of An Immunomediated Inflammatory Process in End-Stage Calcified Aortic Valve Stenosis. Journal of American College of Cardiology, 43, 1670-1676.
|
[38]
|
Syvaranta, S., Helske, S., Laine, M., Lappalainen, J., Kupari, M., Mayranpaa, M.I., Lindstedt, K.A. and Kovanen, P.T. (2010) Vascular Endothelial Growth Factor-Secreting Mast Cells and Myofibroblasts: A Novel Self-Perpetuating Angiogenic Pathway in Aortic Valve Stenosis. Arteriosclerosis, Thrombosis and Vascular Biology, 30, 1220-1227. https://doi.org/10.1161/ATVBAHA.109.198267
|
[39]
|
Hall, E.M. and Ichioka, T. (1940) Etiology of Calcified Nodular Aortic Stenosis. American Journal of Pathology, 16, 761.
|
[40]
|
Hering, D., Faber, L. and Horstkotte, D. (2003) Echocardiographic Features of Radiation-Associated Valvular Disease. American Journal of Cardiology, 92, 226-230.
|
[41]
|
Feigenbaum, H. and Armstrong, W.F. (2005) Feigenbaum’s Echocardiography. 6th Edition, Mitral Valve Disease, Chapter 11, 350.
|
[42]
|
Akram, M.R., Chan, T., McAuliffe, S. and Chenzbraun, A. (2009) Non-Rheumatic Annular Mitral Stenosis: Prevalence and Characteristics. European Journal of Echocardiography, 10, 103-105.
|
[43]
|
Gotoh, T., Kuroda, T., Yamasawa, M., et al. (1995) Correlation between Lipoprotein (a) and Aortic Valve Sclerosis Assessed by Echocardiography (The JMS Cardiac Echo and Cohort Study). American Journal of Cardiology, 76, 928-932.
|
[44]
|
Capuzzi, D.M., Guyton, J.R., Morgan, J.M., et al. (1998) Efficacy and Safety of an Extended-Release Niacin (Niaspan): A Long-Term Study. American Journal of Cardiology, 82, 74U-81U.
|
[45]
|
Merki, E., Graham, M., Taleb, A., et al. (2011) Antisense Oligonucleotide Lowers Plasma Levels of Apolipoprotein (a) and Lipoprotein (a) in Transgenic Mice. Journal of American College of Cardiology, 57, 1611-1621.
|
[46]
|
Rajamannan, N.M., Subramaniam, M., Springett, M., Sebo, T.C., Niekrasz, M., McConnell, J.P., Singh, R.J., Stone, N.J., Bonow, R.D. and Spelsberg, T.C. (2002) Atorvastatin Inhibits Hypercholesterole-mia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve. Circulation, 105, 2660-2665. https://doi.org/10.1161/01.CIR.0000017435.87463.72
|
[47]
|
Rossebo, A.B., Pedersen, T.R., Boman, K., Brudi, P., Chambers, J.B., Egstrup, K., Gerdts, E., Gohlke-Barwolf, C., Holme, I., Kesaniemi, Y.A., Malbecq, W., Nienaber, C.A., Ray, S., Skjaerpe, T., Wachtell, K. and Willenheimer, R. (2008) Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis. New England Journal of Medicine, 359, 1343-1356. https://doi.org/10.1056/NEJMoa0804602
|
[48]
|
Cowell, S.J., Newby, D.E., Prescott, R.J., Bloomfield, P., Reid, J., Northridge, D.B. and Boon, N.A. (2005) A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis. New England Journal of Medicine, 352, 2389-2397. https://doi.org/10.1056/NEJMoa043876
|
[49]
|
Chan, K.L., Teo, K., Dumesnil, J.G., Ni, A. and Tam, J. (2010) Effect of Lipid Lowering with Rosuvastatin on Progress of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (Astronomer) Trial. Circulation, 121, 306-314. https://doi.org/10.1161/CIRCULATIONAHA.109.900027
|
[50]
|
Mundy, G., Garretlt, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M. and Gutierrez, G. (1999) Stimulation of Bone Formation in Vitro and in Rodents by Statins. Science, 286, 1946-1949. https://doi.org/10.1126/science.286.5446.1946
|
[51]
|
Miller, J.D., Weiss, R.M., Serrano, K.M., Brooks, R.M. II, Berry, C.J., Zimmerman, K., Young, S.G. and Heistad, D.D. (2009) Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice. Circulation, 119, 2693-2701. https://doi.org/10.1161/CIRCULATIONAHA.108.834614
|
[52]
|
Yao, Y., Bennett, B.J., Wang, X., Rosenfeld, M.E., Giachelli, C., Lusis, A.J. and Bostrom, K.I. (2010) Inhibition of Bone Morphogenetic Proteins Protects against Atherosclerosis and Vascular Calcification. Circulation Research, 107, 485-494. https://doi.org/10.1161/CIRCRESAHA.110.219071
|
[53]
|
Lemer, R.G., Aronow, W.S., Sekhri, A., Palaniswamy, C., Ahn, C., Singh, T., Sandhu, R. and McClung, J.A. (2009) Warfarin Use and the Risk of Valvular Calcification. Journal of Thrombosis and Haemostasis, 7, 2023-2027. https://doi.org/10.1111/j.1538-7836.2009.03630.x
|
[54]
|
Jahnen-Dechent, W., Heiss, A., Schafer, C. and Ketteller, M. (2011) Fetuin-A Regulation of Calcified Matrix Metabolism. Circulation Research, 108, 1494-1509. https://doi.org/10.1161/CIRCRESAHA.110.234260
|
[55]
|
Kaden, J.J., Reinohl, J.O., Blesch, B., Brueckmann, M., Haghi, D., Borggrefe, M., Schmitz, F., Klomfass, S., Pillich, M. and Ortlepp, J.R. (2007) Systemic and Local Levels of Fetuin-A in Calcific Aortic Valve Stenosis. International Journal of Molecular Medicine, 20, 193-197. https://doi.org/10.3892/ijmm.20.2.193
|
[56]
|
Ix, J.H., Chesrow, G.M., Shlipak, M.G., Brandenburg, V.M., Ketteler, M. and Whooley, M.A. (2007) Association of Fetuin-A with Mitral Annular Calcification and Aortic Stenosis among Persons with Coronary Heart Disease: Data from the Heart and Soul Study. Circulation, 115, 2533-2539. https://doi.org/10.1161/CIRCULATIONAHA.106.682450
|
[57]
|
O.Brien, K.D., Shavelle, D.M., Caulfield, M.T., et al. (2002) Association of Angiotensin-Converting Enzyme with Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma. Circulation, 106, 2224-2230. https://doi.org/10.1161/01.CIR.0000035655.45453.D2
|
[58]
|
Arishiro, K., Hoshiga, M., Negoro, N., et al. (2007) Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits. Journal of American College of Cardiology, 49, 1482-1489.
|
[59]
|
Newby, D.E., Cowell, S.J. and Boon, N.A. (2006) Emerging Medical Treatments for Aortic Stenosis: Statins, Angiotensin Converting Enzyme Inhibitors, or Both? Heart, 92, 729-734. https://doi.org/10.1136/hrt.2005.066852
|
[60]
|
Sattler, A.M., Schoppet, M., Schaefer, J.R. and Hofbauer, L.C. (2004 ) Novel Aspects on Rank Ligand and Osteoproteogerin in Osteoporosis and Vascular Disease. Calcified Tissue International, 74, 103-106. https://doi.org/10.1007/s00223-003-0011-y
|
[61]
|
Bucay, N., Sarosi, I., Dunstan, C.R., et al. (1998) Osteoprotegerin-Deficient Mice Develop Early Onset Osteoporosis and Arterial Calcification. Genes & Development, 12, 1260-1268. https://doi.org/10.1101/gad.12.9.1260
|
[62]
|
Price, P.A., Faus, S.A. and Williamson, M.K. (2001) Bisphosphonates: Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption. Arteriosclerosis, Thrombosis, And Vascular Biology, 21, 817-824. https://doi.org/10.1161/01.ATV.21.5.817
|
[63]
|
Rapoport, H.S., Connolly, J.M., Fulmer, J., et al. (2007) Mechanisms of the in Vivo Inhibition of Calcification of Bioprosthetic Porcine Aortic Valve Cusps and Aortic Wall with Triglycidylamine/Mercapto Bisphosphonate. Biomaterials, 28, 690-699.
|
[64]
|
Aksoy, O., Cam, A., Goel, S.S., Houghtaling, P.L., Williams, S., Ruiz-Rodriguez, E., Menon, V., Kapadia, S.R., Tuzcu, E.M., Blackstone, E.H. and Griffin, B.P. (2012) Do Bisphosphonates Slow the Progression of Aortic Stenosis? Journal of American College of Cardiology, 59, 1452-1459.
|
[65]
|
Xue, T., Mao, Z., Lin, L., Hou, Y., Wei, X., Fu, X., Zhang, J. and Yu, C. (2010) Non-Virus-Mediated Transfer of siRNAs against Runx2 and Smad 4 Inhibit Heterotopic Ossification in Rats. Gene Therapy, 17, 370-379. https://doi.org/10.1038/gt.2009.154
|
[66]
|
Lin, L., Chen, L., Wang, H., Wei, X., Fu, X., Zhang, J., Ma, K., Zhou, C. and Yu, C. (2006) Adenovirus-Mediated Transfer of siRNA against Runx2/Cbfa1 Inhibits the Formation of Heterotopic Ossification in Animal Model. Biochemical and Biophysical Research Communications, 349, 564-572.
|
[67]
|
Shehab, D., Elgazzar, A.H. and Collier, B.D. (2002) Heterotopic Ossification. Journal of Nuclear Medicine, 43, 346-353.
|
[68]
|
Lin, L., Shen, Q., Leng, H., Duan, X., Fu, X. and Yu, C. (2011) Synergistic Inhibition of Endochondral Bone Formation by Silencing Hif1α and Runx2 in Trauma-Induced Heterotopic Ossification. Molecular Therapy, 19, 1426-1432. https://doi.org/10.1038/mt.2011.101
|
[69]
|
Tu, B., Liu, S., Yu, B., Zhu, J., Ruan, H., Tang, T. and Fan, C. (2016) MiR-203 Inhibits the Traumatic Heterotopic Ossification by Targeting Runx2. Cell Death & Disease, 7, e2436.
|
[70]
|
Mishra, S., Vaughn, A.D., Devore, D.I. and Roth, C.M. (2012) Delivery of siRNA Silencing Runx2 Using a Multifunctional Polymer-Lipid Nanoparticle Inhibits Osteogenesis in a Cell Culture Model of Heterotopic Ossification. Integrative Biology, 4, 1498-1507. https://doi.org/10.1039/c2ib20200j
|
[71]
|
Steitz, S.A., Speer, M.Y., Mckee, M.D., Liaw, L., Almeida, M., Yang, H. and Giachelli, C.M. (2012) Osteopontin Inhibits Mineral Deposition and Promotes Regression of Ectopic Calcification. American Journal of Pathology, 161, 2035-2046.
|
[72]
|
Smits, P.C., Van Geuns, R.J., Poldermans, D., Bountioukeios, M., Onderwates, E.E., Lee, C.H., Maat, A.P. and Serruys, P.W. (2003) Catheter-Based Intramyocardial Injection of Autologous Skeletal Myoblasts as a Primary Treatment of Ischemic Heart Failure: Clinical Experience with Six-Month Follow-Up. Journal of American College of Cardiology, 42, 2063-2069.
|
[73]
|
Csoka, A.B., Cao, H., Sammak, P.J., Constantinescu, D., Schatten, G.P. and Hegele, R.A. (2004) Novel Lamin A/C Gene(LMNA) Mutations in Atypical Progeroid Syndrome. Journal of Medical Genetics, 41, 304-308. https://doi.org/10.1136/jmg.2003.015651
|
[74]
|
Natesh, B., Hanumanthappa, G.M., Jeyaranganath, M. and Cholenahally, M.N. (2011) Hutchinson-Gilford Progeria Syndrome with Severe Calcific Aortic Valve Stenosis. Annals of Pediatric Cardiology, 4, 204-206. https://doi.org/10.4103/0974-2069.84670
|
[75]
|
Merideth, M.A., Gordon, L.B., Clauss, S., Sachdev, V., Smith, A.C., Perry, M.B., et al. (2008) Phenotype and Course of Hutchinson-Gilford Progeria Syndrome. New England Journal of Medicine, 358, 592-604. https://doi.org/10.1056/NEJMoa0706898
|
[76]
|
Ravindranath, et al. (2009) Balloon Mitral Valvotomy (BMV) for Calcific Mitral Stenosis, Cardiovascular Interventions. Journal of American College of Cardiology, 2, 263-264.
|
[77]
|
Dugal, J.S., Jetley, V., Sabharwal, J.S., Sofat, S. and Singh, C. (2003) Life-Saving PTMC for Critical Calcific Mitral Stenosis in Cardiogenic Shock with Balloon Impasse. International Journal of Cardiovascular Interventions, 5, 172-174.
|
[78]
|
Goldman, J.H., Slade, A. and Clague, J. (1998) Cardiogenic Shock Secondary to Mitral Stenosis Treated by Balloon Mitral Valvuloplasty. Catheterization and Cardiovascu-lar Diagnosis, 43, 195-197. https://doi.org/10.1002/(SICI)1097-0304(199802)43:2<195::AID-CCD19>3.0. CO;2-N
|
[79]
|
Webb, J.G., Altwegg, L., Boone, R.H., Cheung, A., Ye, J., Lichtenstein, S., Lee, M., Masson, J.B., Thompson, C., Moss, R., Carere, R., Munt, B., Nietlispach, F. and Humphries, K. (2009) Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes. Circulation, 119, 3009-3016. https://doi.org/10.1161/CIRCULATIONAHA.108.837807
|
[80]
|
Guerrero, M., Greenbaum, A. and O’Neill, W. (2014) First in Human Percutaneous Implantation of a Balloon Expandable Transcatheter Heart Valve in a Severely Stenosed Native Mitral Valve. Catheterization and Cardiovascular Interventions, 4, E287-E291. https://doi.org/10.1002/ccd.25441
|
[81]
|
Lim, Z.Y., Boix, R., Prendergast, B., et al. (2015) First Reported Case of Transcatheter Mitral Valve Implantation in Mitral Annular Calcification with a Fully Repositionable and Self-Expanding Valve. Circulation: Cardiovascular Interventions, 8, e003031. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003031
|
[82]
|
Guerrero, M., Dvir, D., Himbert, D., et al. (2016) Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification: Results from the First Multicenter Global Registry. Journal of American College of Cardiology: Cardiovascular Interventions, 9, 1361-1371.
|
[83]
|
Carabello, B.A. and Crawford, F.A. (1997) Valvular Heart Disease. New England Journal of Medicine, 337, 32-41. https://doi.org/10.1056/NEJM199707033370107
|
[84]
|
Pellika, P.A., Sarano, M.E., Nishimura, R.A., et al. (2005) Outcome of 622 Adults with Asymptomatic, Hemodynamically Significant Aortic Stenosis during Prolonged Follow-Up. Circulation, 11, 3290-3295. https://doi.org/10.1161/CIRCULATIONAHA.104.495903
|
[85]
|
Chaliki, H.P., Brown, M.L., Sundt, T.M. and Tajik, A.J. (2007) Timing of Operation in Asymptomatic Severe Aortic Stenosis. Expert Review of Cardiovascular Therapy, 5, 1065-1071. https://doi.org/10.1586/14779072.5.6.1065
|
[86]
|
Pai, R.G., Kapoor, N., Bansal, R.C. and Varadarajan, P. (2006) Malignant Natural History of Asymptomatic Severe Aortic Stenosis: Benefit of Aortic Valve Replacement. Annals of Thoracic Surgery, 82, 2116-2122.
|
[87]
|
Van Meeteren, J. and Schaff, H. (2017) Extracardiac Valved Conduit for Calcific Mitral Stenosis, CTS Net.
|
[88]
|
El-Hamamsy, I., Eryigit, Z., Stevens, L.M., Sarang, Z., George, R., Clark, L., Melina, G., Takkenberg, J.J. and Yacoub, M.H. (2010) Long-Term Outcomes after Autograft versus Homograft Aortic Root Replacement in Adults with Aortic Valve Disease: A Randomised Controlled Trial. The Lancet, 376, 524-531.
|
[89]
|
Contractor, S.G. and Lin, E.C. (2015) Valvular Calcifications, Overview, Imaging of Cardiac Calcifications. Medscape, August 5.
|
[90]
|
Perloff, J.K. (2003) Congenital Aortic Stenosis: Congenital Aortic Regurgitation. In: Perloff, J.K., Ed., Clinical Recognition of Congenital Heart Disease, 5th Edition, Chapter 7, Saunders, Philadelphia, 98.
|
[91]
|
Bartley, O. (1958) Cardiac Valve Calcifications and Registration of Their Movements. Acta Radiologica, 49, 329-347. https://doi.org/10.3109/00016925809170999
|
[92]
|
Teshnizi, M.A., Ghorbanzadeb, A., Zirak, N., Manafi, B. and Moeinipour, A. (2017) Cardiac Calcified Amorphous Tumor of the Mitral Valve Presenting as Transient Ischemic Attack. Case Reports in Cardiology, 2017, Article ID: 2376096.
|
[93]
|
Miller, J.D., Weiss, R.M. and Heistad, D.D. (2011) Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms. Circulation Research, 108, 1392-1412. https://doi.org/10.1161/CIRCRESAHA.110.23413
|